These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 1354878

  • 21. [Neuroleptic large dose therapy of schizophrenias].
    Ungvári G, Pethö B.
    Psychiatr Neurol Med Psychol (Leipz); 1981 Apr; 33(4):230-6. PubMed ID: 6114506
    [Abstract] [Full Text] [Related]

  • 22. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
    Cook B, Hoogenboom G.
    Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745
    [Abstract] [Full Text] [Related]

  • 23. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J, Marcus SC, West J, Countis L, Hall R, Regier DA, Olfson M.
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [Abstract] [Full Text] [Related]

  • 24. [Quality assurance in the psychiatric hospital--joint medical-pharmaceutical visits].
    Reinbold H, Trenckmann U.
    Psychiatr Prax; 1992 Jul; 19(4):96-9. PubMed ID: 1354882
    [Abstract] [Full Text] [Related]

  • 25. A study of the pharmacologic treatment of medication-compliant schizophrenics who relapse.
    Steingard S, Allen M, Schooler NR.
    J Clin Psychiatry; 1994 Nov; 55(11):470-2. PubMed ID: 7989278
    [Abstract] [Full Text] [Related]

  • 26. Algorithm for treatment-refractory schizophrenia.
    Koshino Y.
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S9-13. PubMed ID: 10560891
    [Abstract] [Full Text] [Related]

  • 27. [Treatment refractory schizophrenia].
    Vanelle JM.
    Encephale; 1995 Jun; 21 Spec No 3():13-21. PubMed ID: 7628336
    [Abstract] [Full Text] [Related]

  • 28. High-dose of multiple antipsychotics and cognitive function in schizophrenia: the effect of dose-reduction.
    Kawai N, Yamakawa Y, Baba A, Nemoto K, Tachikawa H, Hori T, Asada T, Iidaka T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug 30; 30(6):1009-14. PubMed ID: 16644082
    [Abstract] [Full Text] [Related]

  • 29. A survey of antipsychotic treatment for schizophrenia in Hong Kong.
    Yip KC, Ungvari GS, Cheung HK, Ng FS, Lau ST.
    Chin Med J (Engl); 1997 Oct 30; 110(10):792-6. PubMed ID: 9642312
    [Abstract] [Full Text] [Related]

  • 30. Factors related to prescription dosage in Japanese psychiatric hospitals.
    Nawata S, Yamauchi K, Ikegami N.
    Psychiatry Clin Neurosci; 2005 Feb 30; 59(1):70-6. PubMed ID: 15679543
    [Abstract] [Full Text] [Related]

  • 31. Insight and schizophrenia.
    Buckley PF, Hasan S, Friedman L, Cerny C.
    Compr Psychiatry; 2001 Feb 30; 42(1):39-41. PubMed ID: 11154714
    [Abstract] [Full Text] [Related]

  • 32. A preliminary dose-ranging trial of proglumide for the treatment of refractory schizophrenics.
    Hicks PB, Vinogradov S, Riney SJ, Su K, Csernansky JG.
    J Clin Psychopharmacol; 1989 Jun 30; 9(3):209-12. PubMed ID: 2567742
    [Abstract] [Full Text] [Related]

  • 33. Clinical correlates of antipsychotic polytherapy in patients with schizophrenia in Singapore.
    Sim K, Su A, Chan YH, Shinfuku N, Kua EH, Tan CH.
    Psychiatry Clin Neurosci; 2004 Jun 30; 58(3):324-9. PubMed ID: 15149301
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Schizophrenia and smoking: an epidemiological survey in a state hospital.
    de Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson GM.
    Am J Psychiatry; 1995 Mar 30; 152(3):453-5. PubMed ID: 7864277
    [Abstract] [Full Text] [Related]

  • 36. Pharmacotherapy of the hospitalized young adult schizophrenic patient.
    Zito JM, Craig TJ, Wanderling J, Siegel C, Green M.
    Compr Psychiatry; 1988 Mar 30; 29(4):379-86. PubMed ID: 2900711
    [Abstract] [Full Text] [Related]

  • 37. [Anesthetic management for schizophrenic patients on chronic phenothiazine therapy (author's transl)].
    Murakawa T, Matsuki A, Oyama T.
    Masui; 1977 Oct 30; 26(10):1154-61. PubMed ID: 21976
    [No Abstract] [Full Text] [Related]

  • 38. The relationship between neuroleptic drug dose and the performance of psychiatric patients in a maximum security token economy program.
    Harris GT.
    J Behav Ther Exp Psychiatry; 1989 Mar 30; 20(1):57-67. PubMed ID: 2570084
    [Abstract] [Full Text] [Related]

  • 39. [Long-term treatment of schizophrenia spectrum disorders: focus on pharmacotherapy].
    Deutschenbaur L, Lambert M, Walter M, Naber D, Huber CG.
    Nervenarzt; 2014 Mar 30; 85(3):363-75; quiz 376-7. PubMed ID: 24603949
    [Abstract] [Full Text] [Related]

  • 40. Changing patterns of neuroleptic dosage over a decade.
    Reardon GT, Rifkin A, Schwartz A, Myerson A, Siris SG.
    Am J Psychiatry; 1989 Jun 30; 146(6):726-9. PubMed ID: 2567122
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.